REFRACTORY MEDULLOBLASTOMA
Clinical trials for REFRACTORY MEDULLOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MEDULLOBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY MEDULLOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising targeted therapy for recurrent brain tumors in kids and young adults
Disease control Recruiting nowThis study is testing a drug called Lutathera in people aged 4 to 39 with certain aggressive brain tumors or meningiomas that have come back or are growing. The drug delivers radiation directly to tumor cells that show up on a special PET scan. The goal is to find the safest dose…
Matched conditions: REFRACTORY MEDULLOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
Engineered immune cells target deadly childhood brain tumors in first human trial
Disease control Recruiting nowThis early-phase trial tests a new treatment for children and young adults with medulloblastoma or similar brain tumors that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack…
Matched conditions: REFRACTORY MEDULLOBLASTOMA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 04, 2026 16:31 UTC